Phase II study of preoperative chemotherapy with paclitaxel (PTX) plus cisplatin (CDDP) for advanced gastric cancer

被引：0
|
作者：
Nagata, N. [1 ]
Tsuburaya, A. [2 ]
Cho, H. [2 ]
Hirabayashi, N. [3 ]
Kobayashi, M. [4 ]
Matsui, T. [5 ]
Munakata, Y. [6 ]
Kameda, Y. [2 ]
Oba, K. [7 ]
Sakamoto, J. [8 ]
机构：
[1] Kitakyushu Gen Hosp, Kitakyushu, Fukuoka, Japan
[2] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan
[3] Hiroshima City Asa Hosp, Hiroshima, Japan
[4] Kochi Med Sch, Nankoku, Kochi, Japan
[5] Aichi Hosp, Aichi Canc Ctr, Okazaki, Aichi, Japan
[6] Nagano Municipal Hosp, Nagano, Japan
[7] Kyoto Univ, Kyoto, Japan
[8] Nagoya Univ, Young Leaders Program, Nagoya, Aichi 4648601, Japan
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71250-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [21] Docetaxel (DTX) plus cisplatin (CDDP) in locally advanced or metastatic head and neck cancer (HN). A phase II study
    Caponigro, F
    De Lucia, L
    Biglietto, M
    Avallone, A
    Rivellini, F
    Sguotti, G
    Manzione, L
    Comella, P
    Mantovani, G
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S168 - S168
  • [22] Phase II study of paclitaxel in pretreated advanced gastric cancer
    Cascinu, S
    Graziano, F
    Cardarelli, N
    Marcellini, M
    Giordani, P
    Menichetti, ET
    Catalano, G
    ANTI-CANCER DRUGS, 1998, 9 (04) : 307 - 310
  • [23] A Phase II Study of Weekly Paclitaxel and Doxifluridine Combination Chemotherapy for Advanced/Recurrent Gastric Cancer
    Takeyoshi, Izumi
    Makita, Fuji
    Tanahashi, Yoshifumi
    Iwazaki, Shigeru
    Ogawa, Tetsushi
    Tomizawa, Naoki
    Nakamura, Seiji
    Ishikawa, Hitoshi
    Ohya, Toshihiro
    Kakinuma, Shinichi
    Nakagami, Katsunao
    Sato, Yoshihiro
    Koyano, Tetsuya
    Roppongi, Takashi
    Izumi, Masaru
    Kobayashi, Junya
    Kawate, Susumu
    Sunose, Yutaka
    Kobayashi, Mitsunobu
    Yamada, Tatsuya
    Sakamoto, Ichiro
    ANTICANCER RESEARCH, 2011, 31 (01) : 287 - 291
  • [24] Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancer
    Koizumi, W
    Fukuyama, Y
    Fukuda, T
    Akiya, T
    Hasegawa, K
    Kojima, Y
    Ohn, N
    Kurihara, M
    ANTICANCER RESEARCH, 2004, 24 (04) : 2465 - 2470
  • [25] Pharmacokinetics (PK) and efficacy of S-1 plus cisplatin (CDDP) in patients with advanced gastric cancer (GC): A phase I/II study.
    Koizumi, W
    Tanabe, S
    Saigenji, K
    Ohtsu, A
    Boku, N
    Nagashima, F
    Muto, M
    CLINICAL CANCER RESEARCH, 2000, 6 : 4573S - 4574S
  • [26] Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial
    Kim, Yeul Hong
    Yamaguchi, Kensei
    Bang, Yung-Jue
    Takiuchi, Hiroya
    Kang, Won Ki
    Sato, Atsushi
    Kang, Yoon-Koo
    Sakamoto, Junichi
    Abe, Chigusa
    Sakata, Yuh
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (07) : 501 - 508
  • [27] Multicenter phase II study of triplet combination chemotherapy with paclitaxel, cisplatin, and S-1 for advanced gastric cancer (OGSG 0703).
    Fujitani, Kazumasa
    Kimura, Yutaka
    Imamura, Hiroshi
    Gotoh, Masahiro
    Iijima, Shohei
    Ueda, Shugo
    Imano, Motohiro
    Oshita, Masahide
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Takiuchi, Hiroya
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [28] Multi-center Phase II Trial of Weekly Paclitaxel Plus Cisplatin Combination Chemotherapy in Patients with Advanced Gastric and Gastro-esophageal Cancer
    Sun, Qing
    Liu, Chaoying
    Zhong, Haijun
    Zhong, Baoliang
    Xu, Haiyuan
    Shen, Wenxiang
    Wang, Daoyuan
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (04) : 237 - 243
  • [29] PHASE II STUDY OF WEEKLY PACLITAXEL, CISPLATIN, AND 5-FLUOROURACIL (PCF) FOR ADVANCED GASTRIC CANCER
    Nishikawa, K.
    Hara, T.
    Sakatoku, M.
    Oba, K.
    Abe, C.
    Sakamoto, J.
    Omura, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 228 - 228
  • [30] Phase II trial of paclitaxel (P) and cisplatin (CDDP) in patients with advanced breast cancer refractory to anthracycline (A) therapy
    Riccardi, F
    Rosati, G
    Biglietto, M
    Carteni, G
    DeRosa, P
    Tucci, A
    Pacilio, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 714 - 714
12345